- 30 years’ experience in novel drug discovery and development
- Currently, Non-Executive Director of Hemoshear Therapeutics and Pharmaxis Ltd., Senior Advisor and Scientific Advisory Board Chair, Bridge Medicines
- Previously, Chief Executive Officer and President of Lycera Corp, Senior Vice President, External Discovery and Preclinical Sciences at Merck & Co, and, prior to that, Senior Vice President, Head of Worldwide Basic Research at Merck & Co, 2005 to 2011. Other leadership positions held at Merck & Co include Vice President, Site Head at Merck Frosst Canada, Basic Research Head of the Respiratory Franchise and Chair of the Respiratory Worldwide Business Strategy Team.
- BSc in Biochemistry from the University of Manchester, PhD from Imperial College of Science and Technology in London, post-doctoral training at the C.N.R.S. in France and the Clinical Research Institute of Montréal. Previously, adjunct Professor in the Department of Pharmacology and Therapeutics at McGill University.